Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia
NCT04341675
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Sirolimus
DRUG:
Placebo
Sponsor
University of Cincinnati